Original Research
Published on 12 Sep 2022
Inverse association between blood ethylene oxide levels and obesity in the general population: NHANES 2013–2016
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.926971
- 6,018 views
- 12 citations
- Frontiers in Endocrinology
- Obesity
- Articles
Type at least 3 characters
1,060 articles
Articles
Original Research
Published on 09 Sep 2022
Hepatic overexpression of protein targeting to glycogen attenuates obesity and improves hyperglycemia in db/db mice
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.969924
- 2,689 views
- 5 citations
Original Research
Published on 09 Sep 2022
Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1004284
- 3,216 views
- 1 citation
Original Research
Published on 08 Sep 2022
Characteristics of adipocytokine expression by local fat depots of the heart: Relationship with the main risk factors for cardio-vascular diseases
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.991902
- 2,302 views
- 1 citation
Original Research
Published on 08 Sep 2022
Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: A population-based prospective study
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.969753
- 3,997 views
- 24 citations
Mini Review
Published on 08 Sep 2022
The role of RNA m6A methylation in lipid metabolism
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.866116
- 9,090 views
- 28 citations
Original Research
Published on 06 Sep 2022
Associations between neck circumference and markers of dysglycemia, non-alcoholic fatty liver disease, and dysmetabolism independent of Body Mass Index in an Emirati population
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.929724
- 3,278 views
- 2 citations
Original Research
Published on 06 Sep 2022
Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.961231
- 4,174 views
- 9 citations
Systematic Review
Published on 05 Sep 2022
Effectiveness of multiple eHealth-delivered lifestyle strategies for preventing or intervening overweight/obesity among children and adolescents: A systematic review and meta-analysis
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.999702
- 4,958 views
- 10 citations
Original Research
Published on 05 Sep 2022
Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.938341
- 3,423 views
- 13 citations
Original Research
Published on 05 Sep 2022
Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1004128
- 3,261 views
- 1 citation
Mini Review
Published on 02 Sep 2022
Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.984041
- 8,174 views
- 3 citations
Original Research
Published on 02 Sep 2022
Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.951689
- 18,259 views
- 62 citations
Systematic Review
Published on 02 Sep 2022
Network meta-analysis of curative efficacy of different acupuncture methods on obesity combined with insulin resistance
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.968481
- 5,309 views
- 2 citations
Original Research
Published on 31 Aug 2022
Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.986841
- 8,267 views
- 10 citations
Original Research
Published on 31 Aug 2022
Body composition of the upper limb associated with hypertension, hypercholesterolemia, and diabetes
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2022.985031
- 3,811 views
- 6 citations